Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Letter

Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals

Online download statistics by month:

Online download statistics by month: June 2021 to August 2023

	Abstract	Full	Pdf
Jun 2021	803	790	232
Jul 2021	376	372	64
Aug 2021	673	670	154
Sep 2021	436	438	101
Oct 2021	219	218	75
Nov 2021	152	154	52
Dec 2021	123	115	19
Jan 2022	155	162	28
Feb 2022	130	128	27
Mar 2022	131	133	25
Apr 2022	95	104	29
May 2022	87	89	30
Jun 2022	68	69	25
Jul 2022	71	71	22
Aug 2022	52	52	10
Sep 2022	74	71	19
Oct 2022	59	57	15
Nov 2022	54	54	11
Dec 2022	42	41	15
Jan 2023	34	35	25
Feb 2023	56	55	16
Mar 2023	28	26	7
Apr 2023	18	18	14
May 2023	28	26	8
Jun 2023	19	20	1
Jul 2023	22	20	10
Aug 2023	26	26	6
Total	4031	4014	1040